Please ensure Javascript is enabled for purposes of website accessibility Global Life Sciences Fund - Janus Henderson Investors - US Advisor
For Financial Professionals in the US

Global Life Sciences Fund Holdings

Full Portfolio Holdings

(As of 07/31/2026)

% OF INVESTMENTS
Eli Lilly & Co 9.24
Johnson & Johnson 7.38
AbbVie Inc 4.70
UnitedHealth Group Inc 4.64
AstraZeneca PLC 3.68
Novartis AG (ADR) 2.79
Thermo Fisher Scientific Inc 2.69
REVOLUTION Medicines Inc 2.67
Argenx SE (ADR) 2.44
Roche Holding AG 2.30
Abbott Laboratories 2.24
Bridgebio Pharma Inc 2.21
CVS Health Corp 2.16
Praxis Precision Medicines Inc 2.03
Merck & Co Inc 1.92
Intuitive Surgical Inc 1.83
Danaher Corp 1.73
Amgen Inc 1.71
Vertex Pharmaceuticals Inc 1.64
Gilead Sciences Inc 1.61
Sanofi SA 1.60
Ascendis Pharma A/S 1.55
Stryker Corp 1.47
Travere Therapeutics Inc 1.39
Boston Scientific Corp 1.24
Madrigal Pharmaceuticals Inc 1.23
HCA Healthcare Inc 1.19
PTC Therapeutics Inc 1.17
Teva Pharmaceutical Industries Ltd (ADR) 1.14
McKesson Corp 1.10
United Therapeutics Corp 1.03
Globus Medical Inc 1.02
Elevance Health Inc 1.02
Mirum Pharmaceuticals Inc 1.01
Dyne Therapeutics Inc 0.95
Vaxcyte Inc 0.88
Lantheus Holdings Inc 0.88
Edwards Lifesciences Corp 0.84
Medtronic PLC 0.81
Cencora Inc 0.67
DexCom Inc 0.65
Medline Inc 0.61
Insmed Inc 0.57
Abivax SA (ADR) 0.55
Definium Therapeutics Inc 0.53
Spyre Therapeutics Inc 0.53
Becton Dickinson & Co 0.51
Edgewise Therapeutics Inc 0.51
UCB SA 0.50
Glaukos Corp 0.49
Ideaya Biosciences Inc 0.47
Oruka Therapeutics Inc 0.46
Structure Therapeutics Inc (ADR) 0.46
Neurocrine Biosciences Inc 0.44
Tarsus Pharmaceuticals Inc 0.37
Xenon Pharmaceuticals Inc 0.36
Centene Corp 0.36
Cogent Biosciences Inc 0.36
Cooper Cos Inc 0.33
Jade Biosciences Inc 0.33
Insulet Corp 0.33
Sotera Health Co 0.31
STERIS PLC 0.31
Regeneron Pharmaceuticals Inc 0.31
Crinetics Pharmaceuticals Inc 0.30
Tango Therapeutics Inc 0.29
Biohaven Ltd 0.28
Humana Inc 0.28
Illumina Inc 0.27
Rhythm Pharmaceuticals Inc 0.27
Heartflow Inc 0.27
Daiichi Sankyo Co Ltd 0.27
Scholar Rock Holding Corp 0.27
Protagonist Therapeutics Inc 0.26
MIRUM PHARMACEUTICALS 0.23
KARDIUM SERIES 8 CLASS D PREFERRED SHARES USD 0.21
Penumbra Inc 0.21
Teleflex Inc 0.21
Apogee Therapeutics Inc 0.20
Parabilis Medicines Inc 0.19
Ardelyx Inc 0.19
4D Molecular Therapeutics Inc 0.15
Olema Pharmaceuticals Inc 0.14
Magnolia Medical Technologies Inc 0.04
Element Biosciences Inc 0.04
Lexeo Therapeutics Inc 0.04
PFIZER INC 0.03
Twinstrand Biosciences Inc 0.02
Freenome Holdings Inc 0.02
Freenome Holdings Inc 0.02
Sonoma Biotherapeutics Inc 0.02
Asher Biotherapeutics Inc 0.01
Sonoma Biotherapeutics Inc 0.01
Attralus Inc 0.01
Asher Biotherapeutics Inc 0.01
Novo Nordisk A/S 0.01
Hemoshear Therapeutics LLC 0.01
Alkermes PLC 0.00
Cash & Equivalents 0.77
Janus Henderson publishes this listing of securities held as of the most recently available disclosure period, which varies depending on the portfolio. Any portion of holdings may be excluded from publication when deemed in the best interest of the portfolio. Securities are reported at market value.
The portfolio data and its presentation here is based on the investment book of record and may differ from the accounting book of record and complete schedules of investments in regulatory filings due to differing accounting and reporting standards.